Velasco-Sampedro E, Sanchez-Vicente C, Caloca M
Molecules. 2025; 30(4).
PMID: 40005135
PMC: 11858732.
DOI: 10.3390/molecules30040824.
Li Z, Shao R, Xin H, Zhu Y, Jiang S, Wu J
Biomolecules. 2025; 15(2).
PMID: 40001476
PMC: 11853175.
DOI: 10.3390/biom15020173.
Liu B, Yasunaga J, Liang Y, Zhou R, Yang S, Yuan X
Proc Natl Acad Sci U S A. 2025; 122(8):e2416412122.
PMID: 39982744
PMC: 11874535.
DOI: 10.1073/pnas.2416412122.
Karbanova J, Thamm K, Fargeas C, Deniz I, Lorico A, Corbeil D
J Nanobiotechnology. 2025; 23(1):61.
PMID: 39881297
PMC: 11776279.
DOI: 10.1186/s12951-025-03102-w.
Ezekiel S, Searle M, Park J
PLoS One. 2025; 20(1):e0317437.
PMID: 39813274
PMC: 11734896.
DOI: 10.1371/journal.pone.0317437.
NEK2 Phosphorylates RhoGDI1 to Promote Cell Proliferation, Migration and Invasion Through the Activation of RhoA and Rac1 in Colon Cancer Cells.
Lim J, Hwang Y, Kim J, Yoon H, Park H, Han J
Cells. 2025; 13(24.
PMID: 39768163
PMC: 11674122.
DOI: 10.3390/cells13242072.
Pan-cancer drivers of metastasis.
Lusby R, Demirdizen E, Inayatullah M, Kundu P, Maiques O, Zhang Z
Mol Cancer. 2025; 24(1):2.
PMID: 39748426
PMC: 11697158.
DOI: 10.1186/s12943-024-02182-w.
High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphoma.
Zhu X, Nong L, Xue X, Feng X
Virchows Arch. 2024; .
PMID: 39630231
DOI: 10.1007/s00428-024-03993-4.
An allosteric inhibitor of RhoGAP class-IX myosins suppresses the metastatic features of cancer cells.
Kyriazi D, Voth L, Bader A, Ewert W, Gerlach J, Elfrink K
Nat Commun. 2024; 15(1):9947.
PMID: 39550360
PMC: 11569205.
DOI: 10.1038/s41467-024-54181-6.
Overcoming Therapy Resistance in Colorectal Cancer: Targeting the Rac1 Signaling Pathway as a Potential Therapeutic Approach.
Anselmino L, Malizia F, Avila A, Cesatti Laluce N, Mamberto M, Zanotti L
Cells. 2024; 13(21.
PMID: 39513883
PMC: 11545287.
DOI: 10.3390/cells13211776.
Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma.
Zhao H, Luo K, Liu M, Cai Y, Liu S, Li S
Front Genet. 2024; 15:1458047.
PMID: 39507618
PMC: 11538069.
DOI: 10.3389/fgene.2024.1458047.
Guanine nucleotide exchange factors and colon neoplasia.
Njei L, Sampaio Moura N, Schledwitz A, Griffiths K, Cheng K, Raufman J
Front Cell Dev Biol. 2024; 12:1489321.
PMID: 39493347
PMC: 11527627.
DOI: 10.3389/fcell.2024.1489321.
A Proteomic Analysis of Nasopharyngeal Carcinoma in a Moroccan Subpopulation.
Reffai A, Hori M, Adusumilli R, Bermudez A, Bouzoubaa A, Pitteri S
Cancers (Basel). 2024; 16(19).
PMID: 39409902
PMC: 11476039.
DOI: 10.3390/cancers16193282.
An Anti-Invasive Role for Mdmx through the RhoA GTPase under the Control of the NEDD8 Pathway.
Bou Malhab L, Schmidt S, Fagotto-Kaufmann C, Pion E, Gadea G, Roux P
Cells. 2024; 13(19.
PMID: 39404389
PMC: 11475522.
DOI: 10.3390/cells13191625.
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model.
Setayesh T, Hu Y, Vaziri F, Wei D, Wan Y
Biomark Res. 2024; 12(1):122.
PMID: 39402682
PMC: 11476289.
DOI: 10.1186/s40364-024-00660-3.
RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential.
Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S
Cancer Cell Int. 2024; 24(1):339.
PMID: 39402585
PMC: 11475559.
DOI: 10.1186/s12935-024-03519-7.
Rho GTPase activating protein 11A promotes tongue squamous cell carcinoma proliferation and is a transcriptional target of forkhead box M1.
Zhang W, Bai X, Liu T, Mao Y, Zhang L, Wang W
J Dent Sci. 2024; 19(4):2268-2277.
PMID: 39347089
PMC: 11437295.
DOI: 10.1016/j.jds.2024.02.015.
The tumorigenic effect of the high expression of ABRACL in glioma and its potential as a therapeutic target.
Zhao C, Wu Z, Yao Z, Zhang F, Zhao R, Cao X
Heliyon. 2024; 10(17):e36597.
PMID: 39286126
PMC: 11402703.
DOI: 10.1016/j.heliyon.2024.e36597.
New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver.
Ramos R, Vinyals A, Campos-Martin R, Cabre E, Bech J, Vaquero J
Cancers (Basel). 2024; 16(17).
PMID: 39272836
PMC: 11394004.
DOI: 10.3390/cancers16172977.
RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
Li Y, Gu A, Yang L, Wang Q
J Cancer Res Clin Oncol. 2024; 150(9):418.
PMID: 39264423
PMC: 11393158.
DOI: 10.1007/s00432-024-05933-w.